Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retinal angiomatosis].

D Schmidt1

  • 1Universitäts-Augenklinik, Freiburg. schmidtd@aug.ukl.uni-freiburg.de

Klinische Monatsblatter Fur Augenheilkunde
|February 19, 2005
PubMed
Summary
This summary is machine-generated.

Von Hippel-Lindau (VHL) disease, a genetic disorder, can cause retinal capillary hemangioblastomas. Early family screening and vigilant monitoring are crucial for managing this multisystem tumor syndrome.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.

The American journal of pathology·1995
Same author

[Placental site trophoblastic tumor. Morphology, differential diagnosis and prognosis].

Der Pathologe·1995
Same author

Retinal vascular hamartoma in von Hippel-Lindau disease.

Archives of ophthalmology (Chicago, Ill. : 1960)·1995
Same author

Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1995
Same author

The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.

Pathology, research and practice·1995
Same author

[Fatigue fractures of the sacrum in primary biliary liver cirrhosis].

Aktuelle Radiologie·1995
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Genetics
  • Oncology

Context:

  • Retinal capillary hemangioblastomas are associated with von Hippel-Lindau (VHL) disease, an autosomal dominant multisystem familial tumor syndrome.
  • VHL disease diagnosis requires identifying characteristic lesions and family history, with retinal hemangioblastomas often manifesting between ages 10-40.

Purpose:

  • To provide an overview of the diagnosis and therapy for VHL disease, focusing on retinal manifestations.
  • To highlight the importance of early detection and comprehensive management strategies for VHL-related tumors.

Summary:

  • VHL disease, linked to the VHL tumor suppressor gene on chromosome 3p25, presents with various tumors, including retinal capillary hemangioblastomas.
  • Treatment options for retinal tumors range from photocoagulation and cryotherapy to advanced methods like proton therapy, radiotherapy, and anti-VEGF therapies.

Related Experiment Videos

  • Presymptomatic diagnosis is possible through DNA markers, and extensive family screening is essential for early detection.

    • Impact:

    • Emphasizes the necessity of interdisciplinary approaches and extensive family screening for early VHL disease detection.
    • Highlights the need for close follow-up of VHL carriers due to the potential for multiple and recurrent tumors.